# Study of Aldafermin (NGM282) in Healthy Adult Male Japanese and Non-Japanese Subjects

> **NCT04828265** · PHASE1 · COMPLETED · sponsor: **NGM Biopharmaceuticals, Inc** · enrollment: 36 (actual)

## Conditions studied

- Healthy Male

## Interventions

- **BIOLOGICAL:** Aldafermin

## Key facts

- **NCT ID:** NCT04828265
- **Lead sponsor:** NGM Biopharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-13
- **Primary completion:** 2021-07-06
- **Final completion:** 2021-07-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2022-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04828265

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04828265, "Study of Aldafermin (NGM282) in Healthy Adult Male Japanese and Non-Japanese Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04828265. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*